View All Blog Posts

Healthy Innovation Statement on COVID-19

Our thoughts are with those affected by the outbreak of COVID-19, the novel strain of the coronavirus, both here in Southeast Asia and around the globe. Addressing the global public health challenges presented by COVID-19 will require collaboration and partnership from stakeholders across the globe. Working together, governments, global health authorities and the private sector can develop solutions to diagnose, treat and prevent the further spread of COVID-19. Now, as always, policies that advance the benefits of healthy innovation are vital to solving public health crises.

For more information about how the industry is responding to the coronavirus crisis, please visit the International Federation of Pharmaceutical Manufacturers and Associations and the Pharmaceutical Research and Manufacturers of America.

Recent Blog Posts

Intellectual Property Accelerates Research and Innovation in Southeast Asia

Intellectual property has enabled unprecedented collaborations to innovate and speed up progress on hundreds of potential COVID-19 treatments, diagnostics and vaccines for the world. As we celebrate World Innovation Day on April 21 and World IP Day on April 26, we are reminded how valuable strong intellectual property laws are to addressing global challenges through innovation.

COVID-19 Shows the Essential Role of Ongoing Health Care Innovation

Great progress had been made in the fight against COVID-19. To date, 32.9% of the world’s population is at least partially vaccinated. Still, the global community has a long way to go before everyone is protected. Continuing to prioritize and support innovation to identify effective treatments, vaccines or boosters, and furthering our understanding of variants, remains critical to the global response.